The impact of doxycycline 100mg PO twice daily for 7 days on the organism load and viability of urethral Mycoplasma genitalium and Chlamydia trachomatis

Monash University0 个研究点目标入组 214 人开始时间: 2022年10月18日最近更新: 2022年10月31日

适应症

试验速览

暂无简介。

•Individuals attending Melbourne Sexual Health Centre (MSHC) will be eligible if they fulfil all the following criteria:
•Are prescribed doxycycline 100mg PO twice daily for 7 days for one of the indications below:
•-men attending MSHC with NGU who receive presumptive doxycycline treatment, or
•-men attending MSHC for doxycycline treatment (100mg PO twice daily for 7 days) for known or presumed/likely M. genitalium or C. trachomatis urethral infection, or
•-men attending MSHC for a urethral M. genitalium test of cure with urethral symptoms and receive presumptive doxycycline treatment, or
•-men attending MSHC as a sexual contact of M. genitalium or C. trachomatis with urethral symptoms in whom doxycycline is presumptively prescribed
•Are aged 18 years and older
•Are willing to participate in research
•Can understand and comply with study procedures

•Individuals will be ineligible if they fulfil any of the following criteria:
•Are currently taking or have been prescribed any antibiotics in addition to doxycycline on the day of enrolment.
•Are not fluent in English
•Are unwilling or unable to comply with study procedures

发起方